Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma

NCT00730444 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT00730444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00730444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma
Lead sponsor
GE Healthcare
Phase
Expanded access
Overall status
Approved for marketing
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma